UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assessment of symptoms in COMET-ICE, a phase 2/3 study of sotrovimab for early treatment of non-hospitalized patients with COVID-19

Journal of patient-reported outcomes, 2023-09, Vol.7 (1), p.92-11, Article 92

2023

Volltextzugriff (PDF)

4.62 A SIX-MONTH OPEN-LABEL EXTENSION STUDY OF VORTIOXETINE IN PEDIATRIC PATIENTS

Journal of the American Academy of Child and Adolescent Psychiatry, 2016-10, Vol.55 (10), p.S183-S183

2016

Volltextzugriff (PDF)

Managing Adverse Effects of Psychotropics in Children

Journal of the American Academy of Child and Adolescent Psychiatry, 2018-10, Vol.57 (10), p.S84-S84

2018

Volltextzugriff (PDF)

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adults With Attention-Deficit/Hyperactivity Disorder

The journal of clinical psychiatry, 2021-08, Vol.82 (5)

2021

Volltextzugriff (PDF)

Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE study

Future virology, 2023-10, Vol.18 (15), p.975-990

2023

Volltextzugriff (PDF)

Resistance analysis in the phase III COMET-TAIL study: treatment of COVID-19 with intramuscular or intravenous sotrovimab

Future virology, 2024-03, Vol.19 (5), p.185-198

2024

Volltextzugriff (PDF)

A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders

Journal of child and adolescent psychopharmacology, 2018-02, Vol.28 (1), p.47-54

2018

Volltextzugriff (PDF)

Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial

Journal of clinical psychopharmacology, 2013-02, Vol.33 (1), p.45-54

2013

Volltextzugriff (PDF)

Atomoxetine Alone or Combined With Fluoxetine for Treating ADHD With Comorbid Depressive or Anxiety Symptoms

Journal of the American Academy of Child and Adolescent Psychiatry, 2005-09, Vol.44 (9), p.915-924

2005

Volltextzugriff (PDF)

Atomoxetine Increased Effect over Time in Adults with Attention‐Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double‐Blind, Placebo‐Controlled, Randomized Trials

CNS neuroscience & therapeutics, 2016-07, Vol.22 (7), p.546-557

2016

Volltextzugriff (PDF)

Atomoxetine monotherapy compared with combination therapy for the treatment of ADHD: a retrospective chart review study

Expert review of neurotherapeutics, 2015-11, Vol.15 (11), p.1353-1366

2015

Volltextzugriff (PDF)

Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab

The New England journal of medicine, 2021-11, Vol.385 (21), p.1941-1950

2021

Volltextzugriff (PDF)

Self-Regulation and Inhibition in Comorbid ADHD Children: An Evaluation of Executive Functions

Journal of attention disorders, 2005-02, Vol.8 (3), p.96-108

2005

Volltextzugriff (PDF)

COMPLIANCE WITH FDA RECOMMENDATIONS FOR PEMOLINE

Journal of the American Academy of Child and Adolescent Psychiatry, 2003-04, Vol.42 (4), p.383-383

Sarkis, Elias H.

2003

Volltextzugriff (PDF)

Atomoxetine and Osmotically Released Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder: Acute Comparison and Differential Response

The American journal of psychiatry, 2008-06, Vol.165 (6), p.721-730

2008

Volltextzugriff (PDF)

GW320659 for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children

Journal of the American Academy of Child and Adolescent Psychiatry, 2002-08, Vol.41 (8), p.914-920

2002

Volltextzugriff (PDF)

1150. Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S353-S354

2021

Volltextzugriff (PDF)

"Model" Behavior

Science (American Association for the Advancement of Science), 2000-03, Vol.287 (5461), p.2160-2162

2000

Volltextzugriff (PDF)

A Mind at a Time: America's Top Learning Expert Shows How Every Child Can Succeed

Journal of the American Academy of Child and Adolescent Psychiatry, 2004-05, Vol.43 (5), p.641-642

Sarkis, Elias H.

2004

Volltextzugriff (PDF)

"Model" Behavior

Science (American Association for the Advancement of Science), 2000-03, Vol.287 (5461), p.2159-2159

Sarkis, Elias H.

2000

Volltextzugriff (PDF)

In vitro Evaluation of the Colistin-Carbapenem Combination in Clinical Isolates of A. baumannii Using the Checkerboard, Etest, and Time-Kill Curve Techniques

Frontiers in cellular and infection microbiology, 2017-05, Vol.7, p.209-209

2017

Volltextzugriff (PDF)

Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study)

The journal of clinical psychiatry, 2011-11, Vol.72 (11), p.1452

2011

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients

Journal of child and adolescent psychopharmacology, 2017-08, Vol.27 (6), p.526-534

2017

Volltextzugriff (PDF)

O Observatório Espacial do Sul

Revista Brasileira de Geofísica, 1997-03, Vol.15 (1), p.65-70

1997

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(26)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Humans
(14)
Psychiatry
(11)
Attention Deficit Hyperactivity Disorder
(10)
Female
(10)
Male
(10)
Attention Deficit Disorder With Hyperactivity - Drug Therapy
(9)
Adolescent
(7)
Child
(7)
Double-Blind Method
(7)
Hyperactivity
(7)
Pediatrics
(7)
Treatment Outcome
(7)
Adult
(6)
Psychology
(6)
Social Sciences
(6)
Anxiety
(5)
Biological And Medical Sciences
(5)
Children
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Assessment of symptoms in COMET-ICE, a phase 2/3 study of sotrovimab for early treatment of non-hospitalized patients with COVID-19

4.62 A SIX-MONTH OPEN-LABEL EXTENSION STUDY OF VORTIOXETINE IN PEDIATRIC PATIENTS

Managing Adverse Effects of Psychotropics in Children

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adults With Attention-Deficit/Hyperactivity Disorder

Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE study

Resistance analysis in the phase III COMET-TAIL study: treatment of COVID-19 with intramuscular or intravenous sotrovimab

A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders

Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial

Atomoxetine Alone or Combined With Fluoxetine for Treating ADHD With Comorbid Depressive or Anxiety Symptoms

Atomoxetine Increased Effect over Time in Adults with Attention‐Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double‐Blind, Placebo‐Controlled, Randomized Trials

Atomoxetine monotherapy compared with combination therapy for the treatment of ADHD: a retrospective chart review study

Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab

Self-Regulation and Inhibition in Comorbid ADHD Children: An Evaluation of Executive Functions

COMPLIANCE WITH FDA RECOMMENDATIONS FOR PEMOLINE

Atomoxetine and Osmotically Released Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder: Acute Comparison and Differential Response

GW320659 for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children

1150. Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab

502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab

"Model" Behavior

A Mind at a Time: America's Top Learning Expert Shows How Every Child Can Succeed

"Model" Behavior

In vitro Evaluation of the Colistin-Carbapenem Combination in Clinical Isolates of A. baumannii Using the Checkerboard, Etest, and Time-Kill Curve Techniques

Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study)

Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients

O Observatório Espacial do Sul

Suchergebnisse filtern